Molina Healthcare, Inc. – Consensus ‘hold’ rating and 2.0% Upside Potential

Broker Ratings
[shareaholic app="share_buttons" id_name="post_below_content"]

Molina Healthcare, Inc. with ticker code (MOH) have now 13 confirmed analysts covering the stock with the consensus suggesting a rating of ‘hold’. The range between the high target price and low target price is between $417.00 and $315.00 and has a mean target at $363.54. Given that the stocks previous close was at $356.25 this is indicating there is a potential upside of 2.0%. The day 50 moving average is $341.50 and the 200 day moving average is $305.00. The market cap for the company is 21.00B. The stock price for the company is currently is currently $360.17 USD

The potential market cap would be $21,427,596,177 based on the market consensus.

The company is not paying dividends at this time.

Other points of data to note are a P/E ratio of 22.43, revenue per share of $563.07 and a 7.12% return on assets.

Molina Healthcare, Inc. is a provider of managed healthcare services under the Medicaid and Medicare programs, and through the state insurance marketplaces. The Company operates through four segments: Medicaid, Medicare, Marketplace, and Other. The Medicaid, Medicare, and Marketplace segments represent the government-funded or sponsored programs under which the Company offers managed healthcare services. Medicaid provides healthcare and long-term care services and support to low-income Americans. Medicare is a federal program that provides eligible persons aged 65 and over and some disabled persons with a variety of hospital, medical insurance, and prescription drug benefits. Marketplace insurance exchanges allow individuals and small groups to purchase federally subsidized health insurance. The Company arranges healthcare services for its members through contracts with a network of providers, including independent physicians and physician groups, hospitals, and ancillary providers.

Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:

      Search

      Search